|Articles|January 10, 2023
Decibel Therapeutics case study
Author(s)Egnyte
Founded in 2015, Decibel is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance. For this growth-stage biotech, Egnyte has been a valuable partner in supporting clinical and regulatory operations, medical writing, biostatistics and data management teams with a single repository for all documentation gathered from CROs and submitted to the FDA and other regulatory agencies.
Trending on Applied Clinical Trials Online
1
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5